메뉴 건너뛰기




Volumn 92, Issue 2, 1997, Pages 204-211

Ulcerative colitis practice guidelines in adults

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; MESALAZINE; OLSALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID;

EID: 0031050776     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (253)

References (119)
  • 1
    • 0027478285 scopus 로고
    • Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis
    • Kornbluth AA, Salomon P, Sacks HS, et al. Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol 1993;16:215-8.
    • (1993) J Clin Gastroenterol , vol.16 , pp. 215-218
    • Kornbluth, A.A.1    Salomon, P.2    Sacks, H.S.3
  • 2
    • 0024602611 scopus 로고
    • The "Natural History" of ulcerative colitis: An analysis of the placebo response
    • Meyers S, Janowitz HD. The "Natural History" of ulcerative colitis: An analysis of the placebo response. Am J Gastroenterol 1989;11: 33-7.
    • (1989) Am J Gastroenterol , vol.11 , pp. 33-37
    • Meyers, S.1    Janowitz, H.D.2
  • 4
    • 0038811981 scopus 로고
    • Endoscopy in inflammatory bowel disease
    • Kirsner JD, Shorter RG, ed. Philadelphia: Lea and Fabiger
    • Waye JD. Endoscopy in inflammatory bowel disease. In: Kirsner JD, Shorter RG, ed. Inflammatory bowel disease. Philadelphia: Lea and Fabiger, 1988, pp 353-76.
    • (1988) Inflammatory Bowel Disease , pp. 353-376
    • Waye, J.D.1
  • 5
    • 0021364710 scopus 로고
    • Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease
    • Surawicz SM, Belic L. Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 1984;86:104-13.
    • (1984) Gastroenterology , vol.86 , pp. 104-113
    • Surawicz, S.M.1    Belic, L.2
  • 6
    • 0023073487 scopus 로고
    • Histopathology differentiates self-limited colitis from ulcerative colitis
    • Nostrant TT, Kumar NB, Appelman HD. Histopathology differentiates self-limited colitis from ulcerative colitis. Gastroenterology 1987;92:318-28.
    • (1987) Gastroenterology , vol.92 , pp. 318-328
    • Nostrant, T.T.1    Kumar, N.B.2    Appelman, H.D.3
  • 7
    • 0038135267 scopus 로고
    • Differential diagnosis of colitis
    • Targan SR, Shanahan R, eds. From Bench to Bedside. Baltimore: Williams and Wilkins
    • Surawicz CM. Differential diagnosis of colitis. In: Targan SR, Shanahan R, eds. Inflammatory Bowel Disease. From Bench to Bedside. Baltimore: Williams and Wilkins, 1994; pp 409-28.
    • (1994) Inflammatory Bowel Disease , pp. 409-428
    • Surawicz, C.M.1
  • 8
    • 0008690916 scopus 로고
    • Cortisone in ulcerative colitis. Final report on a therapeutic trial
    • Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-5.
    • (1955) Br Med J , vol.2 , pp. 1041-1045
    • Truelove, S.C.1    Witts, L.J.2
  • 9
    • 0027534577 scopus 로고
    • Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis
    • Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993;118:540-9.
    • (1993) Ann Intern Med , vol.118 , pp. 540-549
    • Sutherland, L.R.1    May, G.R.2    Shaffer, E.A.3
  • 10
    • 0027236393 scopus 로고
    • Medical therapy of ulcerative colitis
    • Hanauer SB. Medical therapy of ulcerative colitis. Lancet 1993;1: 412-7.
    • (1993) Lancet , vol.1 , pp. 412-417
    • Hanauer, S.B.1
  • 11
    • 50549187947 scopus 로고
    • Sulphasalazine and salicylazophadimidine in ulcerative colitis
    • Baron JH, Connell JE, Lennard-Jones J, et al. Sulphasalazine and salicylazophadimidine in ulcerative colitis. Lancet 1962;1:1094-6.
    • (1962) Lancet , vol.1 , pp. 1094-1096
    • Baron, J.H.1    Connell, J.E.2    Lennard-Jones, J.3
  • 12
    • 84883845710 scopus 로고
    • Controlled trial of sulphasalazine in the treatment of ulcerative colitis
    • Dick AP, Grayson MJ, Carpenter RG, et al. Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 1964;5:437-42.
    • (1964) Gut , vol.5 , pp. 437-442
    • Dick, A.P.1    Grayson, M.J.2    Carpenter, R.G.3
  • 13
    • 0025779674 scopus 로고
    • Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis: A multi-center study
    • Sninsky CA, Cort DH, Shanahan F, et al. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis: A multi-center study. Ann Intern Med 1991;115:350-5.
    • (1991) Ann Intern Med , vol.115 , pp. 350-355
    • Sninsky, C.A.1    Cort, D.H.2    Shanahan, F.3
  • 14
    • 0023521441 scopus 로고
    • Coated oral 5-aminosalicylic therapy for mildly to moderately ulcerative colitis: A randomized trial
    • Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic therapy for mildly to moderately ulcerative colitis: A randomized trial. N Engl J Med 1987;317:1625-9.
    • (1987) N Engl J Med , vol.317 , pp. 1625-1629
    • Schroeder, K.W.1    Tremaine, W.J.2    Ilstrup, D.M.3
  • 15
    • 0025364388 scopus 로고
    • Double-blind, placebo-controlled study of olsalazine in the treatment of ulcerative colitis
    • Zinberg J, Molinas S, Das KM. Double-blind, placebo-controlled study of olsalazine in the treatment of ulcerative colitis. Am J Gastroenterol 1990;85:562-6.
    • (1990) Am J Gastroenterol , vol.85 , pp. 562-566
    • Zinberg, J.1    Molinas, S.2    Das, K.M.3
  • 16
    • 0024433044 scopus 로고
    • Olsalazine versus placebo in the treatment of mild-moderate ulcerative colitis: A randomized double-blind trial
    • Feurle GE, Theuer D, Velasco S, et al. Olsalazine versus placebo in the treatment of mild-moderate ulcerative colitis: A randomized double-blind trial. Gut 1989;30:1354-61.
    • (1989) Gut , vol.30 , pp. 1354-1361
    • Feurle, G.E.1    Theuer, D.2    Velasco, S.3
  • 17
    • 0024359916 scopus 로고
    • Olsalazine or sulphasalazine in first attacks of ulcerative colitis? a double-blind study
    • Rao SS, Dundas SA, Holdsworth CD, et al. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double-blind study. Gut 1989;30:675-9.
    • (1989) Gut , vol.30 , pp. 675-679
    • Rao, S.S.1    Dundas, S.A.2    Holdsworth, C.D.3
  • 18
    • 0023618491 scopus 로고
    • Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine: A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial
    • Meyers S, Sachar DB, Present DH, et al. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine: A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology 1987;93:2255-62.
    • (1987) Gastroenterology , vol.93 , pp. 2255-2262
    • Meyers, S.1    Sachar, D.B.2    Present, D.H.3
  • 19
    • 0023136492 scopus 로고
    • Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant to sulfasalazine
    • Rao SS, Cann PA, Holdsworth CD. Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant to sulfasalazine. Scand J Gastroenterol 1987;22:332-7.
    • (1987) Scand J Gastroenterol , vol.22 , pp. 332-337
    • Rao, S.S.1    Cann, P.A.2    Holdsworth, C.D.3
  • 20
    • 0026530975 scopus 로고
    • Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulfasalazine
    • Giaffer MH, O'Brien CJ, Holdsworth CD. Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulfasalazine. Aliment Pharmacol Ther 1992;6:51-61.
    • (1992) Aliment Pharmacol Ther , vol.6 , pp. 51-61
    • Giaffer, M.H.1    O'Brien, C.J.2    Holdsworth, C.D.3
  • 21
    • 0025322421 scopus 로고
    • Mesalazine (5-ASA) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis
    • Campieri M, Defranchis R, Bianchi G, et al. Mesalazine (5-ASA) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. Scand J. Gastroenterol 1990;25:663-8.
    • (1990) Scand J. Gastroenterol , vol.25 , pp. 663-668
    • Campieri, M.1    Defranchis, R.2    Bianchi, G.3
  • 22
    • 0025049819 scopus 로고
    • 5-aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: A double-blind placebo controlled clinical trial
    • D'Arienzo A, Panarese A, D'Armiento FP, et al. 5-aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: A double-blind placebo controlled clinical trial. Am J Gastroenterol 1990;85:1079-82.
    • (1990) Am J Gastroenterol , vol.85 , pp. 1079-1082
    • D'Arienzo, A.1    Panarese, A.2    D'Armiento, F.P.3
  • 23
    • 0023221030 scopus 로고
    • 5-aminosalicylic acid enemas in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis
    • Sutherland LR, Martin F, Greer S, et al. 5-aminosalicylic acid enemas in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis. Gastroenterology 1987;92:1894-8.
    • (1987) Gastroenterology , vol.92 , pp. 1894-1898
    • Sutherland, L.R.1    Martin, F.2    Greer, S.3
  • 24
    • 0023614327 scopus 로고
    • 5-aminosalicylic acid enemas in the maintenance of remission in distal ulcerative colitis and proctitis
    • Sutherland LR, Martin F. 5-aminosalicylic acid enemas in the maintenance of remission in distal ulcerative colitis and proctitis. Am J Gastroenterol 1987;1:3-6.
    • (1987) Am J Gastroenterol , vol.1 , pp. 3-6
    • Sutherland, L.R.1    Martin, F.2
  • 25
    • 0025359098 scopus 로고
    • Intermittent therapy with high dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis
    • D'Albasio G, Trallori G, Ghetti A, et al. Intermittent therapy with high dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis. Dis Colon Rectum 1990;33:394-7.
    • (1990) Dis Colon Rectum , vol.33 , pp. 394-397
    • D'Albasio, G.1    Trallori, G.2    Ghetti, A.3
  • 26
    • 7144260013 scopus 로고
    • Topical aminosalicylic (ASA) therapy for distal ulcerative colitis: A meta-analysis
    • abstract
    • Marshall JK, Irvine FJ. Topical aminosalicylic (ASA) therapy for distal ulcerative colitis: A meta-analysis. Gastroenterology 1994;106: A1037 (abstract).
    • (1994) Gastroenterology , vol.106
    • Marshall, J.K.1    Irvine, F.J.2
  • 27
    • 0023876851 scopus 로고
    • 5-aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis
    • Biddle WL, Greenberger NJ, Swan JT, et al. 5-aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 1988;94:1075-9.
    • (1988) Gastroenterology , vol.94 , pp. 1075-1079
    • Biddle, W.L.1    Greenberger, N.J.2    Swan, J.T.3
  • 28
    • 0025169657 scopus 로고
    • Topical treatment of ulcerative colitis
    • Sutherland LR. Topical treatment of ulcerative colitis. Med Clin North Am 1990;74:119-31.
    • (1990) Med Clin North Am , vol.74 , pp. 119-131
    • Sutherland, L.R.1
  • 29
    • 0001099178 scopus 로고
    • Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate
    • Watkinson G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate. Br Med J 1958;2:1077-82.
    • (1958) Br Med J , vol.2 , pp. 1077-1082
    • Watkinson, G.1
  • 30
    • 0001099179 scopus 로고
    • Treatment of ulcerative colitis with local hemisuccinate sodium: A report on a controlled clinical trial
    • Truelove SC, Treatment of ulcerative colitis with local hemisuccinate sodium: A report on a controlled clinical trial. Br Med J 1958;2: 1072-7.
    • (1958) Br Med J , vol.2 , pp. 1072-1077
    • Truelove, S.C.1
  • 31
    • 0019467018 scopus 로고
    • Treatment of ulcerative colitis with high dose 5-ASA enemas
    • Campiere M, Lanfranchi GA, Bazzochi G, et al. Treatment of ulcerative colitis with high dose 5-ASA enemas. Lancet 1981;2:270-3.
    • (1981) Lancet , vol.2 , pp. 270-273
    • Campiere, M.1    Lanfranchi, G.A.2    Bazzochi, G.3
  • 32
    • 0022540098 scopus 로고
    • 5-ASA enemas in refractory distal ulcerative colitis: A randomized controlled trial
    • Friedman LS, Richter JM, Kirkham SE, et al. 5-ASA enemas in refractory distal ulcerative colitis: A randomized controlled trial. Am J Gastro 1986;81:412-6.
    • (1986) Am J Gastro , vol.81 , pp. 412-416
    • Friedman, L.S.1    Richter, J.M.2    Kirkham, S.E.3
  • 33
    • 0008337302 scopus 로고
    • Budesonide in distal colitis
    • Danish Budesonide Study Group. Budesonide in distal colitis. Scand J Gastroenterol 1991;26:1225-9.
    • (1991) Scand J Gastroenterol , vol.26 , pp. 1225-1229
  • 34
    • 0018728379 scopus 로고
    • Retrograde spread of hydrocortisone-containing foam given intrarectally in ulcerative colitis
    • Farthing JJ, Rutland JD, Clar JL. Retrograde spread of hydrocortisone-containing foam given intrarectally in ulcerative colitis. Br Med J 1979;2:1822-7.
    • (1979) Br Med J , vol.2 , pp. 1822-1827
    • Farthing, J.J.1    Rutland, J.D.2    Clar, J.L.3
  • 35
    • 0022625839 scopus 로고
    • Retrograde spreading of hydrocortisone enema in inflammatory bowel disease
    • Jay M. Retrograde spreading of hydrocortisone enema in inflammatory bowel disease. Dig Dis Sci 1986;31:139-44.
    • (1986) Dig Dis Sci , vol.31 , pp. 139-144
    • Jay, M.1
  • 36
    • 0026587640 scopus 로고
    • Distribution of mesalamine enemas in patients with active distal ulcerative colitis
    • Chapman NJ. Distribution of mesalamine enemas in patients with active distal ulcerative colitis. Mayo Clin Proc 1992;67:245-8.
    • (1992) Mayo Clin Proc , vol.67 , pp. 245-248
    • Chapman, N.J.1
  • 37
    • 0022540098 scopus 로고
    • 5-ASA enemas in refractory distal ulcerative colitis: A randomized controlled trial
    • Friedman LS, Richter JM, Kirkham SE, et al. 5-ASA enemas in refractory distal ulcerative colitis: A randomized controlled trial. Am J Gastroenterol 1986;81:412-6.
    • (1986) Am J Gastroenterol , vol.81 , pp. 412-416
    • Friedman, L.S.1    Richter, J.M.2    Kirkham, S.E.3
  • 38
    • 0027292761 scopus 로고
    • Mesalamine capsules (Pentasa) for treatment of active ulcerative colitis: Results of a controlled trial
    • Hanauer SB, Schwartz J, Robinson M, et al. Mesalamine capsules (Pentasa) for treatment of active ulcerative colitis: Results of a controlled trial. Am J Gastroenterol 1993;88:1188-97.
    • (1993) Am J Gastroenterol , vol.88 , pp. 1188-1197
    • Hanauer, S.B.1    Schwartz, J.2    Robinson, M.3
  • 39
    • 0024268809 scopus 로고
    • Double-blind comparison of olsalazine and sulfasalazine in active ulcerative colitis
    • Willoughby CP, Cowan RE, Gould SR. Double-blind comparison of olsalazine and sulfasalazine in active ulcerative colitis. Scand J Gastroenterol (suppl) 1988;148:40-4.
    • (1988) Scand J Gastroenterol (Suppl) , vol.148 , pp. 40-44
    • Willoughby, C.P.1    Cowan, R.E.2    Gould, S.R.3
  • 40
    • 0008690916 scopus 로고
    • Cortisone in ulcerative colitis: Report on a therapeutic trial
    • Truelove SC, Witts IJ. Cortisone in ulcerative colitis: Report on a therapeutic trial. Br Med J 1955;2:1041-9.
    • (1955) Br Med J , vol.2 , pp. 1041-1049
    • Truelove, S.C.1    Witts, I.J.2
  • 41
    • 0000206329 scopus 로고
    • An assessment of prednisone, salazopyrine, and topical hydrocortisone hemisuccinate used as outpatient treatment for ulcerative colitis
    • Lennard-Jones JE. An assessment of prednisone, salazopyrine, and topical hydrocortisone hemisuccinate used as outpatient treatment for ulcerative colitis. Gut 1960;1:217-22.
    • (1960) Gut , vol.1 , pp. 217-222
    • Lennard-Jones, J.E.1
  • 42
    • 0000766395 scopus 로고
    • Outpatient treatment of ulcerative colitis
    • Baron JH. Outpatient treatment of ulcerative colitis. Br Med J 1962; 2:441-4.
    • (1962) Br Med J , vol.2 , pp. 441-444
    • Baron, J.H.1
  • 44
    • 0020048415 scopus 로고
    • Controlled trial of azathioprine in chronic ulcerative colitis
    • Kirk AP, Lennard-Jones JE. Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J 1982;284:1291-2.
    • (1982) Br Med J , vol.284 , pp. 1291-1292
    • Kirk, A.P.1    Lennard-Jones, J.E.2
  • 45
    • 0009321827 scopus 로고
    • A controlled trial of azathropine in the treatment of chronic ulcerative colitis
    • Rosenberg JL, Wall AJ, Settles RH, et al. A controlled trial of azathropine in the treatment of chronic ulcerative colitis. Gastroenterology 1973;64:793-801.
    • (1973) Gastroenterology , vol.64 , pp. 793-801
    • Rosenberg, J.L.1    Wall, A.J.2    Settles, R.H.3
  • 46
    • 0008700092 scopus 로고
    • 6-mercaptopurine is an effective steroid-sparing agent in the treatment of refractory ulcerative colitis
    • abstract
    • Liang LC, Rubin PH, Bodian G, et al. 6-mercaptopurine is an effective steroid-sparing agent in the treatment of refractory ulcerative colitis. Gastroenterology 1992;102:A653 (abstract).
    • (1992) Gastroenterology , vol.102
    • Liang, L.C.1    Rubin, P.H.2    Bodian, G.3
  • 47
    • 0025330168 scopus 로고
    • The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis
    • Adler DJ, Korelitz BI. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol 1990;85:717-22.
    • (1990) Am J Gastroenterol , vol.85 , pp. 717-722
    • Adler, D.J.1    Korelitz, B.I.2
  • 48
    • 0025310957 scopus 로고
    • The role of azathioprine in the management of ulcerative colitis
    • Lobo AJ, Foster PN, Burke D, et al. The role of azathioprine in the management of ulcerative colitis. Dis Colon Rectum 1990;33:374-7.
    • (1990) Dis Colon Rectum , vol.33 , pp. 374-377
    • Lobo, A.J.1    Foster, P.N.2    Burke, D.3
  • 49
    • 0026693139 scopus 로고
    • Randomized controlled trial of azathioprine withdrawal in ulcerative colitis
    • Hawthorne AB, Logan RFA, Hawkey CJ, et al. Randomized controlled trial of azathioprine withdrawal in ulcerative colitis. Br Med J 1992;305:20-2.
    • (1992) Br Med J , vol.305 , pp. 20-22
    • Hawthorne, A.B.1    Logan, R.F.A.2    Hawkey, C.J.3
  • 50
    • 0029817846 scopus 로고    scopus 로고
    • The long-term outcome of ulcerative colitis treated with 6-Mercaptopurine
    • George J, Present DH, Pou R, et al. The long-term outcome of ulcerative colitis treated with 6-Mercaptopurine. Am J Gastroenterol 1996;91:1711-4.
    • (1996) Am J Gastroenterol , vol.91 , pp. 1711-1714
    • George, J.1    Present, D.H.2    Pou, R.3
  • 51
    • 49749207893 scopus 로고
    • Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis
    • Misiewicz JJ, Lennard-Jones JE, Connell AM, et al. Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet 1965;1:185-8.
    • (1965) Lancet , vol.1 , pp. 185-188
    • Misiewicz, J.J.1    Lennard-Jones, J.E.2    Connell, A.M.3
  • 52
    • 0015724539 scopus 로고
    • A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)
    • Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin). Gut 1973;14:923-6.
    • (1973) Gut , vol.14 , pp. 923-926
    • Dissanayake, A.S.1    Truelove, S.C.2
  • 53
    • 0018836339 scopus 로고
    • Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis
    • Azad Khan AK, Howes DT, Piris J, et al. Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 1980; 21:232-40.
    • (1980) Gut , vol.21 , pp. 232-240
    • Azad Khan, A.K.1    Howes, D.T.2    Piris, J.3
  • 54
    • 0022649415 scopus 로고
    • Azodisal sodium in the treatment of ulcerative colitis: A study of tolerance and relapse-prevention properties
    • Sandberg-Gertzen H, Jarnerot G, Draaz W. Azodisal sodium in the treatment of ulcerative colitis: A study of tolerance and relapse-prevention properties. Gastroenterology 1986;90:1024-30.
    • (1986) Gastroenterology , vol.90 , pp. 1024-1030
    • Sandberg-Gertzen, H.1    Jarnerot, G.2    Draaz, W.3
  • 55
    • 0023629045 scopus 로고
    • Olsalzine in patients intolerant of SASP
    • Ireland A, Jewell DP. Olsalzine in patients intolerant of SASP. Scand J Gastroenterol 1989;22:1038-40.
    • (1989) Scand J Gastroenterol , vol.22 , pp. 1038-1040
    • Ireland, A.1    Jewell, D.P.2
  • 56
    • 0023920745 scopus 로고
    • Comparison of delayed release 5-aminosalicylic acid, (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis
    • Riley SA, Mani V, Goodman MJ, et al. Comparison of delayed release 5-aminosalicylic acid, (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gut 1988;29: 669-74.
    • (1988) Gut , vol.29 , pp. 669-674
    • Riley, S.A.1    Mani, V.2    Goodman, M.J.3
  • 57
    • 0019972694 scopus 로고
    • Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid
    • Dew MJ, Hughes P, Harries AD, et al. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J 1982;285:1012-4.
    • (1982) Br Med J , vol.285 , pp. 1012-1014
    • Dew, M.J.1    Hughes, P.2    Harries, A.D.3
  • 58
    • 0020560697 scopus 로고
    • Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth
    • Dew MJ, Harries AD, Evans N, et al. Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth. Br Med J 1983;287:413-5.
    • (1983) Br Med J , vol.287 , pp. 413-415
    • Dew, M.J.1    Harries, A.D.2    Evans, N.3
  • 59
    • 0023906720 scopus 로고
    • Comparison of delayed release 5-aminosalicylic acid (mesalazine) and sulphasalazine as maintenance treatment for patients with ulcerative colitis
    • Riley SA, Mani V, Goodman MJ, et al. Comparison of delayed release 5-aminosalicylic acid (mesalazine) and sulphasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 1988;94:1383-9.
    • (1988) Gastroenterology , vol.94 , pp. 1383-1389
    • Riley, S.A.1    Mani, V.2    Goodman, M.J.3
  • 60
    • 0024208726 scopus 로고
    • Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis
    • Mulder CJJ, Tytgat GN, Weterman IT, et al. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 1988;95:1449-53.
    • (1988) Gastroenterology , vol.95 , pp. 1449-1453
    • Mulder, C.J.J.1    Tytgat, G.N.2    Weterman, I.T.3
  • 61
    • 0024951547 scopus 로고
    • Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis
    • Rutgeerts P. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1989;3:183-91.
    • (1989) Aliment Pharmacol Ther , vol.3 , pp. 183-191
    • Rutgeerts, P.1
  • 62
    • 4043130484 scopus 로고
    • Comparison of mesalazine with sulphasalazine in prophylactic treatment of ulcerative colitis
    • abstract
    • Bianchi Porro G, Ardizzone S, Fasoli R, et al. Comparison of mesalazine with sulphasalazine in prophylactic treatment of ulcerative colitis. Gut 1989;30:A1467 (abstract).
    • (1989) Gut , vol.30
    • Bianchi Porro, G.1    Ardizzone, S.2    Fasoli, R.3
  • 63
    • 0025058676 scopus 로고
    • Pentasa in maintenance treatment of ulcerative colitis
    • letter
    • Gionchetti P, Campieri M, Beluzzi A, et al. Pentasa in maintenance treatment of ulcerative colitis. Gastroenterology 1990;98:251-5 (letter).
    • (1990) Gastroenterology , vol.98 , pp. 251-255
    • Gionchetti, P.1    Campieri, M.2    Beluzzi, A.3
  • 64
    • 0026671294 scopus 로고
    • Comparison doses of balsalazide in maintaining ulcerative colitis in remission over 12 months
    • Green JRB, Swan CHJ, Rowlinson A, et al. Comparison doses of balsalazide in maintaining ulcerative colitis in remission over 12 months. Aliment Pharmacol Ther 1992;6:647-52.
    • (1992) Aliment Pharmacol Ther , vol.6 , pp. 647-652
    • Green, J.R.B.1    Swan, C.H.J.2    Rowlinson, A.3
  • 65
    • 0028932679 scopus 로고    scopus 로고
    • Maintenance therapy in ulcerative colitis and Crohn's disease
    • in press
    • Sachar DB. Maintenance therapy in ulcerative colitis and Crohn's disease. J Clin Gastroenterol (in press).
    • J Clin Gastroenterol
    • Sachar, D.B.1
  • 66
    • 0028804562 scopus 로고
    • Safety and efficacy of controlled release mesalamine for maintenance of remission in ulcerative colitis
    • Miner P, Hanauer S, Robinson M, et al. Safety and efficacy of controlled release mesalamine for maintenance of remission in ulcerative colitis. Dig Dis Sci 1995;40:296-304.
    • (1995) Dig Dis Sci , vol.40 , pp. 296-304
    • Miner, P.1    Hanauer, S.2    Robinson, M.3
  • 67
    • 0023921849 scopus 로고
    • Controlled trial comparing olsalazine and sulphasalazine for the maintenance of ulcerative colitis
    • Ireland A, Mason CH, Jewell DP. Controlled trial comparing olsalazine and sulphasalazine for the maintenance of ulcerative colitis. Gut 1988;29:835-7.
    • (1988) Gut , vol.29 , pp. 835-837
    • Ireland, A.1    Mason, C.H.2    Jewell, D.P.3
  • 68
    • 0026595483 scopus 로고
    • Prophylactic effects of olsalazine v sulphasalazine during 12 months of maintenance treatment of ulcerative colitis
    • Killerich S, Ladefoged K, Rennem T, et al. Prophylactic effects of olsalazine v sulphasalazine during 12 months of maintenance treatment of ulcerative colitis. Gut 1992;33:252-5.
    • (1992) Gut , vol.33 , pp. 252-255
    • Killerich, S.1    Ladefoged, K.2    Rennem, T.3
  • 69
    • 0026552099 scopus 로고
    • Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: A prospective, double-blind, randomized multicenter trial
    • Rijk MCM, Van Lier HJJ, van Tongeren JHM. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: A prospective, double-blind, randomized multicenter trial. Am J Gastroenterol 1992;87:438-42.
    • (1992) Am J Gastroenterol , vol.87 , pp. 438-442
    • Rijk, M.C.M.1    Van Lier, H.J.J.2    Van Tongeren, J.H.M.3
  • 70
    • 0024028317 scopus 로고
    • Balasalzide in the maintenance treatment of patients with ulcerative colitis: A double-blind comparison with sulphasalazine
    • McIntyre P, Rodriges CA, Lennard-Jones JE, et al. Balasalzide in the maintenance treatment of patients with ulcerative colitis: A double-blind comparison with sulphasalazine. Aliment Pharmacol Ther 1988;2:237-43.
    • (1988) Aliment Pharmacol Ther , vol.2 , pp. 237-243
    • McIntyre, P.1    Rodriges, C.A.2    Lennard-Jones, J.E.3
  • 71
    • 0024951547 scopus 로고
    • Comparative efficacy of coated, oral 5-aminosalicylic acid (claversal) and sulphasalazine for maintaining remission of ulcerative colitis
    • Rutgeerts P. Comparative efficacy of coated, oral 5-aminosalicylic acid (claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group. Aliment Pharmacol Ther 1989;3:183-91.
    • (1989) International Study Group. Aliment Pharmacol Ther , vol.3 , pp. 183-191
    • Rutgeerts, P.1
  • 72
    • 4043093704 scopus 로고
    • A dose-ranging study of olsalazine in ulcerative colitis
    • Travis SPL, Tysk C, Jarnerot G, et al. A dose-ranging study of olsalazine in ulcerative colitis. Gut 1992;33:546-9.
    • (1992) Gut , vol.33 , pp. 546-549
    • Travis, S.P.L.1    Tysk, C.2    Jarnerot, G.3
  • 73
    • 0026744456 scopus 로고
    • Improved maintenance of remission in ulcerative colitis by balsalazide 4G/day compared to 2G/day
    • Giaffer H, Holdsworth CD, Lennard-Jones JE, et al. Improved maintenance of remission in ulcerative colitis by balsalazide 4G/day compared to 2G/day. Aliment Pharmacol Ther 1992;6:479-85.
    • (1992) Aliment Pharmacol Ther , vol.6 , pp. 479-485
    • Giaffer, H.1    Holdsworth, C.D.2    Lennard-Jones, J.E.3
  • 74
    • 34447493368 scopus 로고
    • Relapse prevention of ulcerative colitis: Double-blind comparison of 1.5 gram vs 3 gram oral mesalazine (Pentasa)
    • abstract
    • Fockens P, Mulder CJJ, Ferwerda J, et al. Relapse prevention of ulcerative colitis: Double-blind comparison of 1.5 gram vs 3 gram oral mesalazine (Pentasa). Gastroenterology 1993;104:A701 (abstract).
    • (1993) Gastroenterology , vol.104
    • Fockens, P.1    Mulder, C.J.J.2    Ferwerda, J.3
  • 75
    • 0001579068 scopus 로고
    • Maintenance of remission of ulcerative colitis by mesalamine (Asacol) versus placebo
    • abstract
    • Hanauer S, Powers B, Robinson M, et al. Maintenance of remission of ulcerative colitis by mesalamine (Asacol) versus placebo. Gastroenterology 1994;106:A696 (abstract).
    • (1994) Gastroenterology , vol.106
    • Hanauer, S.1    Powers, B.2    Robinson, M.3
  • 76
    • 15844361997 scopus 로고
    • Double-blind dose-finding study of olsalazine vs sulfasalazine for maintenance therapy of ulcerative colitis
    • Kruis W, Judmaier G, Kayasseh L, et al. Double-blind dose-finding study of olsalazine vs sulfasalazine for maintenance therapy of ulcerative colitis (abstract). Gastroenterology 1992;102:A649.
    • (1992) Gastroenterology , vol.102
    • Kruis, W.1    Judmaier, G.2    Kayasseh, L.3
  • 77
    • 0026671294 scopus 로고
    • Comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months
    • Green JRB, Swan CHJ, Rowlinson A, et al. Comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months. Aliment Pharmacol Ther 1992;6:647-52.
    • (1992) Aliment Pharmacol Ther , vol.6 , pp. 647-652
    • Green, J.R.B.1    Swan, C.H.J.2    Rowlinson, A.3
  • 78
    • 0016157704 scopus 로고
    • Intensive intravenous regimen for severe attacks of ulcerative colitis
    • Truelove SC, Jewell D. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;1:1067-70.
    • (1974) Lancet , vol.1 , pp. 1067-1070
    • Truelove, S.C.1    Jewell, D.2
  • 79
    • 0018159293 scopus 로고
    • Further experience in the treatment of severe attacks of ulcerative colitis
    • Truelove SC, Willoughby CP, Lee G, et al. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978;2:1086-8.
    • (1978) Lancet , vol.2 , pp. 1086-1088
    • Truelove, S.C.1    Willoughby, C.P.2    Lee, G.3
  • 81
    • 0022505628 scopus 로고
    • Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in ulcerative colitis
    • Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in ulcerative colitis. Gut 1986;27:1210-2.
    • (1986) Gut , vol.27 , pp. 1210-1212
    • Chapman, R.W.1    Selby, W.S.2    Jewell, D.P.3
  • 82
    • 0020560387 scopus 로고
    • Corticotropin vs hydrocortisone in the intravenous treatment of ulcerative colitis
    • Meyers S, Sachar DB, Goldberg JD, et al. Corticotropin vs hydrocortisone in the intravenous treatment of ulcerative colitis. Gastroenterology 1983;85:351-7.
    • (1983) Gastroenterology , vol.85 , pp. 351-357
    • Meyers, S.1    Sachar, D.B.2    Goldberg, J.D.3
  • 83
    • 0016800127 scopus 로고
    • A controlled evaluation of intravenous adrenocorticotropic hormone and hydrocortisone in the treatment of acute colitis
    • Kaplan HP, Portnoy B, Binder HJ, et al. A controlled evaluation of intravenous adrenocorticotropic hormone and hydrocortisone in the treatment of acute colitis. Gastroenterology 1975;69:91-5.
    • (1975) Gastroenterology , vol.69 , pp. 91-95
    • Kaplan, H.P.1    Portnoy, B.2    Binder, H.J.3
  • 84
    • 0017566640 scopus 로고
    • A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis
    • Powell-Tuck J, Bucknell NA, Lennard-Jones JE. A controlled comparison of corticotropin and hydrocortisone in the treatment of severe proctocolitis. Scand J Gastroenterol 1977;12:971-5.
    • (1977) Scand J Gastroenterol , vol.12 , pp. 971-975
    • Powell-Tuck, J.1    Bucknell, N.A.2    Lennard-Jones, J.E.3
  • 85
    • 0025020698 scopus 로고
    • High-dose methylprednisone in the treatment of active ulcerative colitis
    • Rosenberg W, Ireland A, Jewell D. High-dose methylprednisone in the treatment of active ulcerative colitis. J Clin Gastroenterol 1990; 12:40-1.
    • (1990) J Clin Gastroenterol , vol.12 , pp. 40-41
    • Rosenberg, W.1    Ireland, A.2    Jewell, D.3
  • 86
    • 0022392051 scopus 로고
    • Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis
    • Dickinson RJ, O'Connor HJ, Pinder I, et al. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 1985;26:1380-4.
    • (1985) Gut , vol.26 , pp. 1380-1384
    • Dickinson, R.J.1    O'Connor, H.J.2    Pinder, I.3
  • 87
    • 0019142004 scopus 로고
    • Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis
    • Dickinson RJ, Ashton MG, Axon ATR, et al. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 1980;79:1199-2004.
    • (1980) Gastroenterology , vol.79 , pp. 1199-2004
    • Dickinson, R.J.1    Ashton, M.G.2    Axon, A.T.R.3
  • 88
    • 0022516491 scopus 로고
    • Controlled trial of bowel rest in the treatment of severe acute colitis
    • McIntyre DB, Powell-Tuck J, Wood SR. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986;27:481-5.
    • (1986) Gut , vol.27 , pp. 481-485
    • McIntyre, D.B.1    Powell-Tuck, J.2    Wood, S.R.3
  • 89
    • 0025084319 scopus 로고
    • The starved colon-diminished mucosal nutrition, diminished absorption and colitis
    • Roediger WE. The starved colon-diminished mucosal nutrition, diminished absorption and colitis. Dis Colon Rectum 1990;33:858-62.
    • (1990) Dis Colon Rectum , vol.33 , pp. 858-862
    • Roediger, W.E.1
  • 90
    • 4043161587 scopus 로고
    • The treatment of severe ulcerative and Crohn's colitis: A critical analysis of the defined trials
    • Kornbluth A, Marion J, Bharuca S, et al. The treatment of severe ulcerative and Crohn's colitis: A critical analysis of the defined trials. J Clin Gastroenterol 1995;18:242-6.
    • (1995) J Clin Gastroenterol , vol.18 , pp. 242-246
    • Kornbluth, A.1    Marion, J.2    Bharuca, S.3
  • 91
    • 0028292007 scopus 로고
    • Cyclosporine in severe ulcerative colitis refractory to steroid therapy
    • Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330:1841-5.
    • (1994) N Engl J Med , vol.330 , pp. 1841-1845
    • Lichtiger, S.1    Present, D.H.2    Kornbluth, A.3
  • 92
    • 0001288489 scopus 로고
    • Long term results of oral cyclosporine in patients with severe ulcerative colitis: A double-blind, randomized, multi-center trial
    • abstract
    • Kornbluth A, Lichtiger S, Present DH, et al. Long term results of oral cyclosporine in patients with severe ulcerative colitis: A double-blind, randomized, multi-center trial. Gastroenterology 1994;106(2): A714 (abstract).
    • (1994) Gastroenterology , vol.106 , Issue.2
    • Kornbluth, A.1    Lichtiger, S.2    Present, D.H.3
  • 93
    • 0024095412 scopus 로고
    • Medical decompression of toxic megacolon by "rolling."
    • Present DH, Wolfson D, Gelernt IM, et al. Medical decompression of toxic megacolon by "rolling." J Clin Gastroenterol 1988;10:485-90.
    • (1988) J Clin Gastroenterol , vol.10 , pp. 485-490
    • Present, D.H.1    Wolfson, D.2    Gelernt, I.M.3
  • 94
    • 0027458081 scopus 로고
    • Toxic megacolon: The knee-elbow position relieves bowel distension
    • Panos MS, Wood MJ, Asquith P. Toxic megacolon: The knee-elbow position relieves bowel distension. Gut 1993;34:1726-7.
    • (1993) Gut , vol.34 , pp. 1726-1727
    • Panos, M.S.1    Wood, M.J.2    Asquith, P.3
  • 96
    • 0014483588 scopus 로고
    • Fate of the rectum and distal colon after subtotal colectomy for ulcerative colitis
    • Korelitz BI, Dyck WP, Klion FM. Fate of the rectum and distal colon after subtotal colectomy for ulcerative colitis. Gut 1969;10:198-201.
    • (1969) Gut , vol.10 , pp. 198-201
    • Korelitz, B.I.1    Dyck, W.P.2    Klion, F.M.3
  • 97
    • 0025293943 scopus 로고
    • Management of severe hemorrhage in ulcerative colitis
    • Robert JH, Sachar DB, Aufses AH, et al. Management of severe hemorrhage in ulcerative colitis. Am J Surg 1990;159:550-5.
    • (1990) Am J Surg , vol.159 , pp. 550-555
    • Robert, J.H.1    Sachar, D.B.2    Aufses, A.H.3
  • 98
    • 0021825291 scopus 로고
    • Outcome of toxic dilation in ulcerative and Crohn's colitis
    • Greenstein AJ, Sachar DB, Gorbas A, et al. Outcome of toxic dilation in ulcerative and Crohn's colitis. J Clin Gastroenterol 1985;7:137-44.
    • (1985) J Clin Gastroenterol , vol.7 , pp. 137-144
    • Greenstein, A.J.1    Sachar, D.B.2    Gorbas, A.3
  • 99
    • 0022361675 scopus 로고
    • Surveillance for colorectal cancer in ulcerative colitis
    • Rosenstock E, Farmer RG, Petras R, et al. Surveillance for colorectal cancer in ulcerative colitis. Gastroenterology 1985;89:1342.
    • (1985) Gastroenterology , vol.89 , pp. 1342
    • Rosenstock, E.1    Farmer, R.G.2    Petras, R.3
  • 101
    • 0019379322 scopus 로고
    • Dysplasia associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis: An indication for colectomy
    • Blackstone M, Riddell RW, Rogers BHG, et al. Dysplasia associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis: An indication for colectomy. Gastroenterology 1981;80:366-74.
    • (1981) Gastroenterology , vol.80 , pp. 366-374
    • Blackstone, M.1    Riddell, R.W.2    Bhg, R.3
  • 102
    • 0026777059 scopus 로고
    • Benign and malignant colorectal strictures in ulcerative colitis
    • Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992;33:938-41.
    • (1992) Gut , vol.33 , pp. 938-941
    • Gumaste, V.1    Sachar, D.B.2    Greenstein, A.J.3
  • 103
    • 0028057219 scopus 로고
    • Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy
    • Reiser JR, Waye JD, Janowitz HD, et al. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol 1994;89:119-22.
    • (1994) Am J Gastroenterol , vol.89 , pp. 119-122
    • Reiser, J.R.1    Waye, J.D.2    Janowitz, H.D.3
  • 104
    • 0028126001 scopus 로고
    • Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis
    • Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis. Lancet 1994;343:71-4.
    • (1994) Lancet , vol.343 , pp. 71-74
    • Bernstein, C.N.1    Shanahan, F.2    Weinstein, W.M.3
  • 105
    • 0028064988 scopus 로고
    • Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
    • Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
    • (1994) Gastroenterology , vol.107 , pp. 934-944
    • Connell, W.R.1    Lennard-Jones, J.E.2    Williams, C.B.3
  • 106
    • 0026634758 scopus 로고
    • Surveillance in the routine management of ulcerative colitis: The predictive value of low grade dysplasia
    • Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: The predictive value of low grade dysplasia. Gastroenterology 1992;103:431-8.
    • (1992) Gastroenterology , vol.103 , pp. 431-438
    • Woolrich, A.J.1    DaSilva, M.D.2    Korelitz, B.I.3
  • 107
    • 0020582146 scopus 로고
    • Does intestinal resection heal the pyoderma of inflammatory bowel disease?
    • Talansky A, Meyers S, Greenstein AJ, et al. Does intestinal resection heal the pyoderma of inflammatory bowel disease? J Clin Gastroenterol 1983;5:207-10.
    • (1983) J Clin Gastroenterol , vol.5 , pp. 207-210
    • Talansky, A.1    Meyers, S.2    Greenstein, A.J.3
  • 108
    • 0018405402 scopus 로고
    • Autoimmune hemolytic anemia in ulcerative colitis
    • Altman AR, Maltz CR, Janowitz HD. Autoimmune hemolytic anemia in ulcerative colitis. Dig Dis Sci 1979;24:282-5.
    • (1979) Dig Dis Sci , vol.24 , pp. 282-285
    • Altman, A.R.1    Maltz, C.R.2    Janowitz, H.D.3
  • 109
    • 0015037829 scopus 로고
    • Autoimmune hemolytic anemia in ulcerative colitis cured by colectomy
    • Arner O. Autoimmune hemolytic anemia in ulcerative colitis cured by colectomy. Acta Med Scand 1971;189:275-8.
    • (1971) Acta Med Scand , vol.189 , pp. 275-278
    • Arner, O.1
  • 110
    • 0018357266 scopus 로고
    • Cancer in ulcerative and left-sided ulcerative colitis: Factors determining risk
    • Greenstein AJ, Sachar DB, Smith H, et al. Cancer in ulcerative and left-sided ulcerative colitis: Factors determining risk. Gastroenterology 1979;77:290-4.
    • (1979) Gastroenterology , vol.77 , pp. 290-294
    • Greenstein, A.J.1    Sachar, D.B.2    Smith, H.3
  • 111
    • 0025979693 scopus 로고
    • Colorectal cancer in ulcerative colitis: Influence of anatomical extent and age at onset on colitis-cancer interval
    • Sugita A, Sachar DB, Bodian C, et al. Colorectal cancer in ulcerative colitis: Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 1991;32:167-9.
    • (1991) Gut , vol.32 , pp. 167-169
    • Sugita, A.1    Sachar, D.B.2    Bodian, C.3
  • 112
    • 0023907386 scopus 로고
    • Colorectal cancer in patients with ulcerative colitis: A population study in central Israel
    • Gilat T, Fireman Z, Grossman A, et al. Colorectal cancer in patients with ulcerative colitis: A population study in central Israel. Gastroenterology 1988;94:870-7.
    • (1988) Gastroenterology , vol.94 , pp. 870-877
    • Gilat, T.1    Fireman, Z.2    Grossman, A.3
  • 113
    • 4043168684 scopus 로고
    • Cancer risk in inflammatory bowel disease: Myths and Metaphors
    • Riddel RH, ed. New York: Elsevier
    • Sachar DB. Cancer risk in inflammatory bowel disease: Myths and Metaphors. In: Riddel RH, ed. Dysplasia and cancer in colitis. New York: Elsevier, 1991, pp 5-9.
    • (1991) Dysplasia and Cancer in Colitis , pp. 5-9
    • Sachar, D.B.1
  • 114
    • 0018425634 scopus 로고
    • Cancer in universal and left-sided ulcerative colitis: Clinical and pathological features
    • Greenstein AJ, Sachar DB, Pucillo A, et al. Cancer in universal and left-sided ulcerative colitis: Clinical and pathological features. Mt Sinai J Med 1979;46:25-32.
    • (1979) Mt Sinai J Med , vol.46 , pp. 25-32
    • Greenstein, A.J.1    Sachar, D.B.2    Pucillo, A.3
  • 115
    • 0023856775 scopus 로고
    • Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centers
    • Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centers. Gut 1988;29:206-17.
    • (1988) Gut , vol.29 , pp. 206-217
    • Gyde, S.N.1    Prior, P.2    Allan, R.N.3
  • 116
    • 0022653273 scopus 로고
    • Comparison of multiple synchronous colorectal cancers in ulcerative colitis, familial polyposis coli, and de novo cancer
    • Greenstein AJ, Slater G, Heimann TM, et al. Comparison of multiple synchronous colorectal cancers in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg 1986;203:123-8.
    • (1986) Ann Surg , vol.203 , pp. 123-128
    • Greenstein, A.J.1    Slater, G.2    Heimann, T.M.3
  • 117
    • 0027981530 scopus 로고
    • Cancer surveillance in ulcerative colitis: More of the same or progress?
    • Vemulapalli R, Lance P. Cancer surveillance in ulcerative colitis: More of the same or progress? Gastroenterology 1994;107:1196-9.
    • (1994) Gastroenterology , vol.107 , pp. 1196-1199
    • Vemulapalli, R.1    Lance, P.2
  • 118
    • 0024396703 scopus 로고
    • Hazard rates for dysplasia and cancer in ulcerative colitis: Results from a surveillance program
    • Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis: Results from a surveillance program. Dig Dis Sci 1989;10:1536-41.
    • (1989) Dig Dis Sci , vol.10 , pp. 1536-1541
    • Lashner, B.A.1    Silverstein, M.D.2    Hanauer, S.B.3
  • 119
    • 0024465973 scopus 로고
    • Observer study of the grading of dysplasia in ulcerative colitis: Comparison with clinical outcome
    • Melville DM, Jass JR, Morson BC, et al. Observer study of the grading of dysplasia in ulcerative colitis: Comparison with clinical outcome. Hum Pathol 1989;20:1008-14.
    • (1989) Hum Pathol , vol.20 , pp. 1008-1014
    • Melville, D.M.1    Jass, J.R.2    Morson, B.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.